Terms: = Bone cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169
184 results:
1. The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol.
Banu MA; Raza SM; Amini M; Seaman S; Rubino F; Snyder R; Patel S; DeMonte F; Conley AP
Neurosurg Focus; 2024 May; 56(5):E15. PubMed ID: 38691867
[TBL] [Abstract] [Full Text] [Related]
2. A novel t(X;21)(p11.4;q22.12) translocation adds to the role of BCOR and RUNX1 in myelodysplastic syndromes and acute myeloid leukemias.
Mavridou E; Lema Fernandez AG; Nardelli C; Pierini V; Quintini M; Arniani S; Di Giacomo D; Crescenzi B; Matteucci C; Sambani C; Mecucci C
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23235. PubMed ID: 38656651
[TBL] [Abstract] [Full Text] [Related]
3. Exosome miR-101-3p derived from bone marrow mesenchymal stem cells promotes radiotherapy sensitivity in non-small cell lung cancer by regulating DNA damage repair and autophagy levels through ezh2.
Sun H; Zhu R; Guo X; Zhao P; Zhang R; Zhao Z; Zhou H
Pathol Res Pract; 2024 Apr; 256():155271. PubMed ID: 38574630
[TBL] [Abstract] [Full Text] [Related]
4. MiR26a reverses enzalutamide resistance in a bone-tumor targeted system with an enhanced effect on bone metastatic CRPC.
Wang Y; Chen J; Gong L; Wang Y; Siltari A; Lou YR; Murtola TJ; Gao S; Gao Y
J Nanobiotechnology; 2024 Apr; 22(1):145. PubMed ID: 38566211
[TBL] [Abstract] [Full Text] [Related]
5. Nuclear medicine practice in Japan: a report of the ninth nationwide survey in 2022.
Okizaki A; Nishiyama Y; Inui Y; Otsuka H; Takanami K; Nakajo M; Nakatani K; Nogami M; Hirata K; Maeda Y; Yoshimura M; Wakabayashi H
Ann Nucl Med; 2024 Apr; 38(4):315-327. PubMed ID: 38421515
[TBL] [Abstract] [Full Text] [Related]
6. Epigenetic reprogramming of T cells: unlocking new avenues for cancer immunotherapy.
Singh V; Nandi S; Ghosh A; Adhikary S; Mukherjee S; Roy S; Das C
Cancer Metastasis Rev; 2024 Mar; 43(1):175-195. PubMed ID: 38233727
[TBL] [Abstract] [Full Text] [Related]
7. BMP-ACVR1 Axis is Critical for Efficacy of PRC2 Inhibitors in B-Cell Lymphoma.
Liu D; Li Z; Tan D; An Y; Chu L; Chen T; Li W; Zhou A; Xiang R; Zhang L; Qu Y; Qi W
Adv Sci (Weinh); 2024 Mar; 11(12):e2306499. PubMed ID: 38229201
[TBL] [Abstract] [Full Text] [Related]
8. Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study.
Song Y; Jin Z; Li ZM; Liu Y; Li L; He C; Su H; Zhou H; Li K; Hao S; Zuo X; Wu J; Li D; Wu M; Sun X; Qi J; Cai Z; Li Z; Li Y; Huang Y; Shen J; Xiao Z; Zhu J
Clin Cancer Res; 2024 Apr; 30(7):1248-1255. PubMed ID: 38190117
[TBL] [Abstract] [Full Text] [Related]
9. JAK2 R683S Mutation Resulting in Dual Diagnoses of Chronic Eosinophilic Leukemia and Myelodysplastic/Myeloproliferative Overlap Syndrome.
Krah NM; Miotke L; Li P; Patel JL; Bowen AR; Pomicter AD; Patel AB
J Natl Compr Canc Netw; 2023 Dec; 21(12):1218-1223. PubMed ID: 38081125
[TBL] [Abstract] [Full Text] [Related]
10. Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets.
Høland M; Berg KCG; Eilertsen IA; Bjerkehagen B; Kolberg M; Boye K; Lingjærde OC; Guren TK; Mandahl N; van den Berg E; Palmerini E; Smeland S; Picci P; Mertens F; Sveen A; Lothe RA
EBioMedicine; 2023 Nov; 97():104829. PubMed ID: 37837931
[TBL] [Abstract] [Full Text] [Related]
11. Diagnosis- and Prognosis-Related Gene Alterations in
Morishita S; Komatsu N
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629188
[No Abstract] [Full Text] [Related]
12.
Nylund P; Garrido-Zabala B; Párraga AA; Vasquez L; Pyl PT; Harinck GM; Ma A; Jin J; Öberg F; Kalushkova A; Wiklund HJ
Haematologica; 2024 Feb; 109(2):567-577. PubMed ID: 37496441
[TBL] [Abstract] [Full Text] [Related]
13. Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.
Jain T; Tsai HL; Elmariah H; Vachhani P; Karantanos T; Wall SA; Gondek LP; Bashey A; Keyzner A; Tamari R; Grunwald MR; Abedin S; Nadiminti KV; Iqbal M; Gerds AT; Viswabandya A; McCurdy SR; Al Malki MM; Varadhan R; Ali H; Gupta V; Jones RJ; Otoukesh S
Haematologica; 2023 Dec; 108(12):3321-3332. PubMed ID: 37408464
[TBL] [Abstract] [Full Text] [Related]
14. Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of ezh2 mutations in follicular lymphoma.
Nagy Á; Bátai B; Kiss L; Gróf S; Király PA; Jóna Á; Demeter J; Sánta H; Bátai Á; Pettendi P; Szendrei T; Plander M; Körösmezey G; Alizadeh H; Kajtár B; Méhes G; Krenács L; Timár B; Csomor J; Tóth E; Schneider T; Mikala G; Matolcsy A; Alpár D; Masszi A; Bödör C
J Intern Med; 2023 Sep; 294(3):295-313. PubMed ID: 37259686
[TBL] [Abstract] [Full Text] [Related]
15. Capsaicin Reduces cancer Stemness and Inhibits Metastasis by Downregulating
Chen ZY; Huang HH; Li QC; Zhan FB; Wang LB; He T; Yang CH; Wang Y; Zhang Y; Quan ZX
Am J Chin Med; 2023; 51(4):1041-1066. PubMed ID: 37120706
[TBL] [Abstract] [Full Text] [Related]
16. Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms.
Nannya Y; Tobiasson M; Sato S; Bernard E; Ohtake S; Takeda J; Creignou M; Zhao L; Kusakabe M; Shibata Y; Nakamura N; Watanabe M; Hiramoto N; Shiozawa Y; Shiraishi Y; Tanaka H; Yoshida K; Kakiuchi N; Makishima H; Nakagawa M; Usuki K; Watanabe M; Imada K; Handa H; Taguchi M; Kiguchi T; Ohyashiki K; Ishikawa T; Takaori-Kondo A; Tsurumi H; Kasahara S; Chiba S; Naoe T; Miyano S; Papaemanuil E; Miyazaki Y; Hellström-Lindberg E; Ogawa S
Blood Adv; 2023 Jul; 7(14):3624-3636. PubMed ID: 36989067
[TBL] [Abstract] [Full Text] [Related]
17. Molecular Evidence for Olfactory Neuroblastoma as a Tumor of Malignant Globose Basal Cells.
Zunitch MJ; Fisch AS; Lin B; Barrios-Camacho CM; Faquin WC; Tachie-Baffour Y; Louie JD; Jang W; Curry WT; Gray ST; Lin DT; Schwob JE; Holbrook EH
Mod Pathol; 2023 May; 36(5):100122. PubMed ID: 36841178
[TBL] [Abstract] [Full Text] [Related]
18. LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of ezh2.
Duan Y; Yue K; Ye B; Chen P; Zhang J; He Q; Wu Y; Lai Q; Li H; Wu Y; Jing C; Wang X
Cell Death Dis; 2023 Feb; 14(2):149. PubMed ID: 36813772
[TBL] [Abstract] [Full Text] [Related]
19. Expression of Enhancer of Zeste Homolog 2 (ezh2) Gene in Acute Myeloid Leukemia.
Hamed NAM; El Ghandour A; Abo Elwafa RA; Rezk MR; Ghallab O
Asian Pac J Cancer Prev; 2023 Jan; 24(1):81-85. PubMed ID: 36708555
[TBL] [Abstract] [Full Text] [Related]
20. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome.
Eckardt JN; Stasik S; Röllig C; Sauer T; Scholl S; Hochhaus A; Crysandt M; Brümmendorf TH; Naumann R; Steffen B; Kunzmann V; Einsele H; Schaich M; Burchert A; Neubauer A; Schäfer-Eckart K; Schliemann C; Krause SW; Herbst R; Hänel M; Hanoun M; Kaiser U; Kaufmann M; Rácil Z; Mayer J; Cerqueira T; Kroschinsky F; Berdel WE; Serve H; Müller-Tidow C; Platzbecker U; Baldus CD; Schetelig J; Siepmann T; Bornhäuser M; Middeke JM; Thiede C
Blood Cancer J; 2023 Jan; 13(1):18. PubMed ID: 36693840
[TBL] [Abstract] [Full Text] [Related]
[Next]
